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Tyrosine kinases of the JAK family are required for
activation of both STAT transcription factors and the
ERK/MAP kinase pathway, suggesting a mechanism for
the optimization of gene induction via the coordinate
activation of multiple transcription factors.
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Members of the extracellular signal-regulated kinase
subfamily of the mitogen-activated protein kinases —
ERK/MAPKs — are activated both by growth factors,
which bind to receptors with intrinsic tyrosine kinase
activity, and by cytokines, the receptors for which lack
tyrosine kinase activity. In the former case, autophospho-
rylated tyrosine residues in the activated receptor provide
the binding sites for adaptor proteins, such as Shc or Grb2,
which localize the guanine nucleotide exchange factor,
Sos, to the plasma membrane. Sos, in turn, activates the
guanine-nucleotide binding protein, Ras, a nearly invari-
ant early step in the pathway leading to the activation of
ERK/MAPKs. 
It would thus seem logical that the activation of
ERK/MAPKs by cytokines should also require the activa-
tion of an unidentified tyrosine kinase. The first clue as to
the identity of such a tyrosine kinase came with the
finding that erythropoietin (Epo) and growth hormone
(GH) activate a member of the Janus kinase (JAK) family
of tyrosine kinases (reviewed in [1]). JAKs were first iden-
tified as upstream activators of a family of latent cytoplas-
mic transcription factors known as ‘signal transducers and
activators of transcription’ (STATs) [2], which are involved
in the induction of interferon (IFN)-responsive genes. It
now seems that JAKs may be required for activation of
both STATs and ERK/MAPKs by cytokines, providing a
mechanism for the optimization of gene induction.
JAK-mediated activation of STATs
The JAK family is presently comprised of four mammalian
enzymes — JAKs 1, 2 and 3 and Tyk2 — and a Drosophila
homologue, Hopscotch. Six mammalian STAT genes have
been isolated [3], and it is now recognized that
JAK–STAT pathways are activated by most cytokines, by
growth factors that bind to receptor tyrosine kinases, and
by the ligand-induced activation of certain trimeric G-
protein-coupled receptors [3]. In contrast to the apparently
obligatory role for JAKs in the activation of STATs by
cytokines, the tyrosine kinase activity of the epidermal
growth factor (EGF) receptor seems to be sufficient for
STAT activation, even though JAK1 is activated in
response to EGF [4]. Thus, JAK activation may serve diff-
erent functions for distinct classes of receptor.
A general model for the JAK-mediated activation of
STATs by cytokines is shown in Figure 1. Ligand binding
results in the dimerization (or multimerization) of the
receptor subunits and consequent activation of one or
more JAKs. Although there may be exceptions, it is gener-
ally the case that those multi-subunit cytokine receptors
that use a common signalling subunit (such as gp130)
undergo ligand-dependent activation of the same JAK
family members. Reports vary as to whether JAKs are con-
stitutively associated with the receptor or associate with
the receptor following ligand binding; moreover, it is not
known whether the association of JAKs with the receptor
is direct. Nevertheless, JAK activation depends on the
integrity of a proline-rich sequence within a membrane-
proximal region of the receptor subunits’ cytoplasmic
domains.
Activated JAKs generally phosphorylate tyrosine residues
on one of the receptor subunits, thereby providing sites for
binding by the Src-homology 2 (SH2) domains of specific
STATs. The bound STATs are then phosphorylated on a
single tyrosine, presumably by the receptor-associated
JAKs, dimerize via high-affinity reciprocal SH2–phospho-
tyrosine interactions, and are translocated to the nucleus.
In the nucleus, the STAT dimers bind to response
elements in the promoters of ligand-responsive genes. The
binding of particular STATs to ligand-activated receptors
seems to be dictated by the affinity of the STAT SH2
domains [5] for specific sequences carboxy-terminal of the
receptor phosphotyrosine residue [6]. As STAT activation
by interleukin-6 (IL-6) [7] or platelet-derived growth factor
(PDGF) [8], for example, has been found to persist in cells
expressing a dominant-negative mutant form of Ras, it has
been presumed that JAK-mediated phosphorylation and
activation of STATs generally occurs in a Ras-independent
manner.
JAK activation of STAT and ERK/MAPK pathways
Most ligands that activate JAK–STAT pathways also acti-
vate the pathway leading to ERK/MAPK activation.
Deleting parts of cytokine receptors [1] or JAKs [9] in such
a way as to abrogate receptor–JAK association and JAK
activation prevents not only STAT activation but also
ERK/MAPK activation, suggesting that the latter as well
as the former may require JAK activation. Indeed, this
seems to be the case. ERK2/MAPK activation following
GH stimulation of transfected cells expressing the GH
receptor was recently shown to require coexpression and
activation of JAK2 [10]. Han et al. [11] similarly found, by
complementation experiments with a mutant cell line,
that JAK2 was necessary for GH-stimulated tyrosine phos-
phorylation of the adaptor molecule Shc, which is required
for Shc to associate with Grb2–Sos [11].
Although JAK-mediated activation of STATs has been
reported to be Ras-independent, JAK2-mediated activa-
tion of ERK2/MAPK by GH failed to occur in transfected
cells expressing dominant-negative mutant forms of either
Ras or Raf [10]. In other studies, GH was found to stimu-
late the tyrosine phosphorylation and/or DNA-binding
activity of STATs 1, 3, and 5 ([11] and references therein).
The Ras dependence of this activation was not evaluated,
but if the Ras independence of JAK-mediated STAT acti-
vation turns out to be a general property, JAK2 would
seem to be a common upstream component of at least two
GH-activated signalling pathways that bifurcate upstream
of Ras activation (Fig. 2). ERK/MAPK activation is abro-
gated on mutation of the putative JAK-binding domain in
several cytokine receptors [1], suggesting that JAK tyrosine
kinases are likely to be general mediators of ERK/MAPK
activation by cytokines.
Potential mechanisms of JAK-mediated Ras activation
How do JAK proteins mediate activation of Ras by recep-
tors that lack intrinsic tyrosine kinase activity? The most
straightforward mechanism would be that tyrosine
residues in the ligand-activated receptor are phosphory-
lated by the activated JAK, providing binding sites for the
coupling of Ras-regulating proteins. This may indeed be
the case for ERK/MAPK activation by hematopoietic
growth factors, for example, as carboxy-terminal trunca-
tions of the receptors for several such growth factors atten-
uate or preclude tyrosine phosphorylation of Shc and/or
the activation of ERK/MAPK [12–14]. Whether this is the
universal mechanism for ERK/MAPK activation by
cytokines is presently not clear, as receptor binding sites
for the adaptor proteins that mediate binding and translo-
cation of Sos-linked adaptor proteins have not been sys-
tematically identified, as they have in several receptor
tyrosine kinases. Moreover, there seems to be no require-
ment for phosphorylatable tyrosine residues on the GH
receptor for some cellular responses to GH, including cell
proliferation and JAK–STAT activation [15], despite the
fact that the GH receptor is phosphorylated on tyrosine in
JAK2-expressing cells [11].
A possible alternative mechanism for Ras activation via
cytokine receptors is that Sos-linked adaptor proteins bind
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Figure 1
A general model of the JAK–STAT pathway
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to a phosphotyrosine on the activated JAK (Fig. 2). This
possibility is supported by the observations that GH stim-
ulates tyrosine phosphorylation of the adaptor protein Shc,
and that JAK2 from GH-treated cells binds in vitro to a
fusion protein containing the Shc SH2 domain [16]. Simi-
larly, JAK2 has been shown to coimmunoprecipitate with
Shc in Epo-treated cells expressing mutant Epo receptors
that lack cytoplasmic tyrosines [17]. Activated JAKs are
also able to bind to fusion proteins bearing STAT SH2
domains in vitro [18], suggesting that JAKs may provide
docking sites for multiple signalling molecules.
Another potential mechanism for Ras activation is that
Sos-linked adaptor proteins, such as Grb2, may bind to
phosphotyrosines in the insulin receptor tyrosine kinase
substrate 1 (IRS-1), which is known to be tyrosine phos-
phorylated upon treatment with certain cytokines [19].
This explanation is complicated, however, by the fact
that IL-4 can activate JAKs and STATs and induce tyro-
sine phosphorylation of IRS-1, but it does not activate
Ras or ERK/MAPK. This suggests that JAK activation
and IRS-1 phosphorylation may not be sufficient for
ERK/MAPK activation, or perhaps that IL-4 stimulates
the phosphorylation of IRS-1 tyrosines different from
those phosphorylated following receptor stimulation by
ligands that activate ERK/MAPKs.
Crosstalk between ERK/MAPK and STAT pathways?
There is evidence that the activities of STAT1a and
STAT3 are additionally enhanced by cytokine/growth-
factor-stimulated serine phosphorylation [20], which
seems to occur in the cytoplasm (J. Darnell, personal com-
munication). The major site of STAT1a serine phospho-
rylation in cytokine/growth-factor-stimulated cells was
identified as serine 727 (S727) [20]. Serine phosphoryla-
tion may influence the ability of STATs to activate tran-
scription by regulating formation of the complex of factors
that regulate transcription from a single response element,
as is known to occur for transcription factors such as
CREB. Others have suggested that serine phosphorylation
increases the DNA-binding affinity of STATs [21].
Several lines of evidence suggest that ERK/MAPKs could
be STAT kinases. S727 in STAT1a lies within an
ERK/MAPK consensus sequence — PM/LSP — con-
served in STATs 1a, 3, 4 and 5. A phosphopeptide
encompassing this sequence is phosphorylated in vitro by
Xenopus ERK/MAPK, and PDGF — which activates
ERK/MAPK — stimulates S727 phosphorylation in vivo
[20]. In other studies, ERK2/MAPK was found to coim-
munoprecipitate with STAT1a in IFN-treated cells, and
overexpression of a dominant-negative mutant form of
ERK2/MAPK diminished IFNb-stimulated transcription
of a reporter construct driven by the ISRE, a response
element that binds activated STATs [22]. But whether
this attenuation of transcription resulted from loss of S727
phosphorylation of STAT1a was not determined, and
whether IFNs really do activate ERK/MAPKs is still con-
troversial. It may prove to be the case that proline-directed
protein kinases other than ERK/MAPKs are the in vivo
STAT serine kinases. It does, however, seem that maximal
STAT transactivating activity requires both tyrosine and
serine phosphorylation (Fig. 2).
Are JAKs Raf kinases?
Is the role of JAKs in ERK/MAPK activation limited to the
ability to create phosphotyrosine sites for coupling to Sos,
or might JAKs also influence the activity of other compo-
nents of the signalling pathway leading to ERK/MAPK
activation, such as Raf? Raf activation seems to be initiated
by its Ras-mediated recruitment to the plasma membrane.
Plasma membrane localization is not, however, sufficient
for the full activation of Raf, for which additional steps,
such as phosphorylation on serine and/or tyrosine residues,
may be required.
A physiological Raf tyrosine kinase has not been identi-
fied, but Marais et al. [23] have found that coexpression of
Raf-1, v-Ras and constitutively active (Y527F) Src in
mammalian cells results in the activation of Raf and its
phosphorylation on tyrosines 340 and 341, the same sites
phosphorylated in insect cells expressing activated Src or,
to a lesser extent, the PDGF receptor. Other results from
these studies, however, suggest that Raf may be regulated
by phosphorylation of tyrosines in addition to tyrosines
340 and 341. Indeed, JAKs may be Raf kinases. Roberts
and co-workers have found that JAK2 physically associates
Figure 2
JAK2-mediated activation of STATs and ERK/MAPKs by GH and/or a




















with Raf in both Sf9 cells and in Epo- or IFN-stimulated
mammalian cells (T. Roberts, personal communication).
Moreover, Y340F/Y341F mutant Raf is tyrosine phospho-
rylated when coexpressed in insect cells with JAK2, but
not with Src, and coexpression of JAK2, Raf and Ras
results in the activation of Raf. JAKs may thus activate Raf
either alone or in concert with Src family kinases. The sig-
nificance of JAK-mediated Raf phosphorylation awaits
mapping of the phosphorylated tyrosine residues and the
subsequent evaluation of the effect of their mutation on
ERK/MAPK activation.
Signalling-pathway cooperation to enhance transcription
Piecing together the available data, it would seem that
JAKs function as upstream components of at least two
signalling pathways that bifurcate upstream of Ras, one
leading to the activation of STATs and the other to
activation of ERK/MAPKs. The most immediate conse-
quence of this coordinate activation is likely to be the
enhancement of the transcription of genes whose induc-
tion is regulated both by response elements that bind
STATs (such as the Sis-inducible element, SIE) and
those that bind ERK/MAPK-activated transcription
factors (such as the serum response element, SRE).
ERK/MAPK-activated transcription factors include Elk-1
and Sap-1a (members of the ternary complex factor sub-
family of the Ets transcription factor family that can bind
to the SRE in conjunction with the serum response
factor, SRF), ER81, Ets-1 and Ets-2 [24], and CBP
(which can form protein–protein interactions with SRE-
bound factors; R. Janknecht, personal communication).
Thus, transcription of the c-fos gene is enhanced by the
coordinate activation of transcription factors that bind to
the SIE and those that bind to the SRE in its promoter
[25]. The physiological relevance of this dual activation is
supported by the fact that most cytokines that activate
STATs also activate ERK/MAPKs. Coordinate activation
may also prove to be important in the Hopscotch (JAK),
Marelle (STAT) and Pointed (an ERK/MAPK-regulated
transcription factor) pathways in Drosophila. Cooperation
between multiple signalling pathways may thus be a
highly conserved mechanism for maximizing the induction
of single genes.
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